Disease modification and symptom relief in osteoarthritis using a mutated GCP-2/CXCL6 chemokine.
Caxaria S, Kouvatsos N, Eldridge SE, Alvarez-Fallas M, Thorup AS, Cici D, Barawi A, Arshed A, Strachan D, Carletti G, Huang X, Bharde S, Deniz M, Wilson J, Thomas BL, Pitzalis C, Cantatore FP, Sayilekshmy M, Sikandar S, Luyten FP, Pap T, Sherwood JC, Day AJ, Dell'Accio F.
Caxaria S, et al. Among authors: thomas bl.
EMBO Mol Med. 2023 Jan 11;15(1):e16218. doi: 10.15252/emmm.202216218. Epub 2022 Dec 12.
EMBO Mol Med. 2023.
PMID: 36507558
Free PMC article.